Search Results

Disease-Modifying Drugs for Adult-Onset Rheumatoid Arthritis.

• Authors : Faison, Maya N.¹; Davis, Andrew M.¹ ; Trotter, Kimberly C.²

Subjects: *ANTIRHEUMATIC agents; *RHEUMATOID arthritis; *RHEUMATISM

• Source: JAMA: Journal of the American Medical Association. 3/26/2024, Vol. 331 Issue 12, p1055-1056. 2p.

Record details

Discontinuation of Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Excellent Disease Control.

• Authors : Lillegraven, Siri (AUTHOR); Paulshus Sundlisæter, Nina (AUTHOR); Aga, Anna-Birgitte (AUTHOR)

Subjects: ANTIRHEUMATIC agents; PREVENTIVE medicine; CLINICAL trials

• Source: JAMA: Journal of the American Medical Association. 3/28/2023, Vol. 329 Issue 12, p1024-1026. 3p.

Record details

Hydroxychloroquine Dose per Ophthalmology Guidelines and the Risk of Systemic Lupus Erythematosus Flares.

• Authors : Jorge, April M. (AUTHOR); Mancini, Christian (AUTHOR); Zhou, Baijun (AUTHOR)

Subjects: RELATIVE medical risk; ANTIRHEUMATIC agents; MEDICAL protocols

• Source: JAMA: Journal of the American Medical Association. 10/11/2022, Vol. 328 Issue 14, p1458-1460. 3p.

Record details

Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial.

• Authors : Lillegraven, Siri; Paulshus Sundlisæter, Nina; Aga, Anna-Birgitte

Subjects: REDUCTION of drug dosage; ANTIRHEUMATIC agents; DISEASE remission

• Source: JAMA: Journal of the American Medical Association. 5/4/2021, Vol. 325 Issue 17, p1755-1764. 10p.

Record details

Effect of Magnetic Resonance Imaging vs Conventional Treat-to-Target Strategies on Disease Activity Remission and Radiographic Progression in Rheumatoid Arthritis: The IMAGINE-RA Randomized Clinical Trial.

• Authors : Møller-Bisgaard, Signe; Hørslev-Petersen, Kim; Ejbjerg, Bo

Subjects: ANTIRHEUMATIC agents; BONE marrow; COMPARATIVE studies

• Source: JAMA: Journal of the American Medical Association. 2/5/2019, Vol. 321 Issue 5, p461-472. 12p.

Record details

Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs and Disease Flare in Patients With Rheumatoid Arthritis.

• Authors : Baker, Kenneth Frank¹; Pratt, Arthur Grant¹; Isaacs, John Dudley¹

Subjects: *DRUG efficacy; *ANTIRHEUMATIC agents; *RHEUMATOID arthritis treatment

• Source: JAMA: Journal of the American Medical Association. 9/7/2021, Vol. 326 Issue 9, p872-873. 2p.

Record details

Incorrect Data in Table.

Subjects: ANTIRHEUMATIC agents; RHEUMATOID arthritis

• Source: JAMA: Journal of the American Medical Association. 5/9/2023, Vol. 329 Issue 18, p1612-1612. 1p.

Record details

Achieving Clinical Remission for Patients With Rheumatoid Arthritis.

• Authors : Aletaha, Daniel¹; Smolen, Josef S.¹

Subjects: *ANTIRHEUMATIC agents; *MAGNETIC resonance imaging; *RHEUMATOID arthritis

• Source: JAMA: Journal of the American Medical Association. 2/5/2019, Vol. 321 Issue 5, p457-458. 2p.

Record details

Receipt of Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis in Medicare Managed Care Plans.

• Authors : Schmajuk, Gabriela (AUTHOR); Trivedi, Amal N. (AUTHOR); Solomon, Daniel H. (AUTHOR)

Subjects: ANTIRHEUMATIC agents; RHEUMATOID arthritis; SOCIODEMOGRAPHIC factorsUNITED States

• Source: JAMA: Journal of the American Medical Association. 2/2/2011, Vol. 305 Issue 5, p480-486. 7p. 3 Charts, 1 Graph.

Record details

Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs and Disease Flare in Patients With Rheumatoid Arthritis-Reply.

• Authors : Lillegraven, Siri; Paulshus Sundlisæter, Nina; Haavardsholm, Espen A.

Subjects: DRUG efficacy; ANTIRHEUMATIC agents; RHEUMATOID arthritis treatment

• Source: JAMA: Journal of the American Medical Association. 9/7/2021, Vol. 326 Issue 9, p873-873. 1p.

Record details